Kate Watabayashi
Research Subjects
Research Interests
Kate Watabayashi has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Diana S. M. Buist
Kaiser Permanente Washington Health Research Institute, Seattle, WA
1 shared publication - J. David Beatty
D Fred Hutchinson Cancer Research Center and Swedish Hospital
1 shared publication - Jason D. Thorpe
B Fred Hutchinson Cancer Research Center
1 shared publication - Jessica Chubak
Group Health Research Institute, Seattle, WA
1 shared publication - M. Robyn Andersen
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
1 shared publication - Nancy Hanson
E Swedish Hospital
1 shared publication
Latest Publications
- 3 November 2014
- Published by Taylor & Francis in Behavioral Medicine
- Vol. 42 (1) , 18-28
Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk for ovarian cancer. To understand what percentage of women with high-risk family histories know their risk is elevated we surveyed 1,885 women with a high- or moderate-risk family history and no personal history of breast or ovarian cancer, and asked about their perceived risk of breast and ovarian cancer. Among high-risk women, fewer than 20% reported use of genetic counseling, and knowledge of elevated risk of ovarian cancer was low. Prior genetic counseling was associated with greater perceived risk for ovarian cancer. Results suggest that most high-risk women (>75%) do not know their risk for ovarian cancer. Identification of potentially high-risk women for referral to genetic counseling may improve informed ovarian cancer risk management.
- 3 November 2014
- Published by Taylor & Francis in Behavioral Medicine
- Vol. 42 (1) , 18-28
Cancer Risk Awareness and Concern among Women with a Family History of Breast or Ovarian Cancer
Women with a documented deleterious mutation in BRCA1 or BRCA2 are at substantially elevated risk for ovarian cancer. To understand what percentage of women with high-risk family histories know their risk is elevated we surveyed 1,885 women with a high- or moderate-risk family history and no personal history of breast or ovarian cancer, and asked about their perceived risk of breast and ovarian cancer. Among high-risk women, fewer than 20% reported use of genetic counseling, and knowledge of elevated risk of ovarian cancer was low. Prior genetic counseling was associated with greater perceived risk for ovarian cancer. Results suggest that most high-risk women (>75%) do not know their risk for ovarian cancer. Identification of potentially high-risk women for referral to genetic counseling may improve informed ovarian cancer risk management.